Omeros Corp
General ticker "OMER" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $597.0M
Omeros Corp follows the US Stock Market performance with the rate: 38.0%.
Estimated limits based on current volatility of 12.8%: low 9.35$, high 12.10$
Factors to consider:
- Current price 253.4% above estimated high
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [1.28$, 3.17$]
- 2023-12-31 to 2024-12-30 estimated range: [1.19$, 2.83$]
Financial Metrics affecting the OMER estimates:
- Negative: Non-GAAP EPS, $ of -2.76 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -39.66 <= 2.35
- Negative: Industry operating cash flow per share per price (median), % of -15.82 <= 3.85
- Positive: Interest expense per share, $ of 0.36 <= 0.74
- Positive: Inventory ratio change, % of -0.03 <= 0
Short-term OMER quotes
Long-term OMER plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $156.92MM | $173.62MM | $163.39MM |
| Operating Income | $-156.92MM | $-173.62MM | $-163.39MM |
| Non-Operating Income | $-39.47MM | $-17.93MM | $-18.64MM |
| Interest Expense | $26.75MM | $19.67MM | $22.70MM |
| R&D Expense | $110.82MM | $118.78MM | $112.72MM |
| Income(Loss) | $-196.39MM | $-191.55MM | $-182.03MM |
| Taxes | $-23.26MM | $0.00MM | $0.00MM |
| Other Income(Loss) | $35.07MM | $385.78MM | $229.45MM |
| Profit(Loss) | $-138.06MM | $194.24MM | $47.42MM |
| Stockholders Equity | $-120.75MM | $23.78MM | $85.68MM |
| Inventory | $114.55MM | $0.00MM | $0.00MM |
| Assets | $181.04MM | $419.27MM | $590.97MM |
| Operating Cash Flow | $-100.09MM | $-109.72MM | $-86.48MM |
| Capital expenditure | $0.28MM | $0.28MM | $0.11MM |
| Investing Cash Flow | $-67.03MM | $193.71MM | $-127.56MM |
| Financing Cash Flow | $174.53MM | $6.32MM | $124.25MM |
| Earnings Per Share* | $-2.41 | $3.12 | $0.46 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.